VANCOUVER, Wash. and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Guggenheim Securities SMID Cap Biotech Conference in New York, NY.
Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Seeking Alpha / 1 hour from now 1 Views
Comments